Clinical Trials Browser

Dyspnea, Multiple Myeloma, Cardiotoxicity

NCT04790266 2025-11-18

CARDIOTOX

Completed

150 enrolled

Cardiotoxicity

NCT06605833 2025-10-01

CARD-IO

Enrolling by invitation

60 enrolled

Dermatologic

Melanoma, Cardiotoxicity

NCT07041827 2025-06-27

CLARITY

Completed

217 enrolled

Lymphoid

Cardiovascular Diseases, Heart Failure, Lymphoma, Non-Hodgkin, Cardiomyopathies, Metabolic Syndrome, Cardiotoxicity

NCT06664528 2025-03-04

CV_CANCER

Recruiting

300 enrolled

Neoplasms, Cardiotoxicity

NCT06597045 2024-09-19

BIOCAPRI

Active not recruiting

60 enrolled

Neoplasms, Atherosclerosis, Cardiotoxicity

NCT05851053 2024-05-29

BLOC-II

Recruiting

455 enrolled

Breast

Breast Neoplasms, Heart Failure, Ventricular Dysfunction, Cardiotoxicity

NCT06282796 2024-02-28

Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

Recruiting

600 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT05939089 2023-07-11

CASPER

Completed

54 enrolled

Heart Failure, Ventricular Dysfunction, Left, Cardiotoxicity

NCT04867564 2021-07-23

Radiation-induced Cardiac Toxicity After Non-small Cell Lung Cancer Radiotherapy

Unknown

100 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Radiation Injuries, Cardiotoxicity

Clinical Trials

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

CARDIOTOX

CARD-IO

CLARITY

CV_CANCER

BIOCAPRI

BLOC-II

Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

CASPER

Radiation-induced Cardiac Toxicity After Non-small Cell Lung Cancer Radiotherapy